Paradigm Biopharmaceuticals Limited

ASX (AUD): Paradigm Biopharmaceuticals Limited (PAR)

Last Price

0.47

Today's Change

+0.025 (5.61%)

Day's Change

0.445 - 0.495

Trading Volume

4,550,740

Overview

Market Cap

183 Million

Shares Outstanding

389 Million

Avg Volume

2,092,828

Avg Price (50 Days)

0.37

Avg Price (200 Days)

0.28

PE Ratio

-2.35

EPS

-0.20

Earnings Announcement

26-Feb-2025

Previous Close

0.45

Open

0.46

Day's Range

0.445 - 0.495

Year Range

0.165 - 0.61

Trading Volume

4,550,740

Price Change Highlight

1 Day Change

5.62%

5 Day Change

18.99%

1 Month Change

-12.15%

3 Month Change

141.03%

6 Month Change

62.07%

Ytd Change

17.50%

1 Year Change

10.59%

3 Year Change

-73.82%

5 Year Change

-84.44%

10 Year Change

30.07%

Max Change

30.07%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment